drugset / Trial / NCT01195363
Quetiapine Sr as Adjunctive Treatment In Mixed States of Bipolar Disorder
Phase 4
Completed
28 enrolled
The University of Texas Health Science Center at San Antonio
AstraZeneca · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
To assess the acute and long-term bimodal efficacy of QTP, as an adjunct to ongoing treatment with lithium (Li) or divalproex (DIV) or lamotrigine (LAM) or any combination of the three thereof, in a group of patients with an index episode of a mixed state in BD.
Timeline
- Start
- 2007-04
- Primary completion
- 2010-12
- Completion
- 2011-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Quetiapine | Small molecule | — | Oral |